Long-term remission of neovascular age-related macular degeneration with as-needed anti-vascular endothelial growth factor therapy
Retina Mar 02, 2018
Muftuoglu IK, et al. - Experts aimed to assess the presenting characteristics of cases having neovascular age-related macular degeneration with long-term remission (LTR). In this study, LTR was defined as the absence of intraretinal/subretinal fluid or hemorrhage, and absence of leakage on fluorescein angiography for longer than 6 months while on as-needed antivascular endothelial growth factor treatment. Findings suggested that in subjects receiving as-required treatment for age-related macular degeneration, the presence of retinal angiomatous proliferation, thinner choroidal thickness, more intraretinal fluid, and less subretinal fluid at presentation was associated with LTR.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries